Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: HAIZUM ON BEHALF OF ANGIODROID
Firm Income Reported for This Client
$70K
Not substituted for client expenses
Summary
HAIZUM ON BEHALF OF ANGIODROID is an organization. Its political footprint includes $70K in lobbying-firm income reported for this client. Lobbying activity focuses on Medical/Disease Research/Clinical Labs.